You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR ZANUBRUTINIB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for zanubrutinib

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02569476 ↗	BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies	Completed	BeiGene	Phase 1	2016-01-13	This study evaluated the safety and preliminary efficacy of BGB-3111 (zanubrutinib) in combination with obinutuzumab in participants with B-cell lymphoid malignancies.
NCT02795182 ↗	Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies	Completed	BeiGene	Phase 1	2016-06-29	This study is evaluating the safety and preliminary efficacy of BGB-3111 in combination with BGB-A317 in participants with B-cell lymphoid malignancies.
NCT02914938 ↗	A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma	Recruiting	Clinipace LTD	Phase 1	2016-10-01	A Three-Arm Study of ME-401 in Subjects with Relapsed/Refractory CLL/SLL or FL, of ME-401 in Combination with Rituximab in Subjects with Relapsed/Refractory CLL/SLL or B-cell NHL, and of ME-401 in Combination with Zanubrutinib in Subjects with Relapsed/Refractory CLL/SLL or B-cell NHL
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for zanubrutinib

Condition Name

Chart
Table

Condition Name for zanubrutinib
Intervention	Trials
Diffuse Large B Cell Lymphoma	11
Mantle Cell Lymphoma	11
Small Lymphocytic Lymphoma	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for zanubrutinib
Intervention	Trials
Lymphoma	53
Lymphoma, Large B-Cell, Diffuse	27
Lymphoma, B-Cell	26
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for zanubrutinib

Trials by Country

Map
Table

Trials by Country for zanubrutinib
Location	Trials
United States	204
China	153
Australia	61
United Kingdom	19
Japan	19
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for zanubrutinib
Location	Trials
New York	14
Texas	13
Florida	13
California	11
New Jersey	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for zanubrutinib

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for zanubrutinib
Clinical Trial Phase	Trials
Phase 3	14
Phase 2/Phase 3	1
Phase 2	58
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for zanubrutinib
Clinical Trial Phase	Trials
Recruiting	46
Not yet recruiting	30
Completed	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for zanubrutinib

Sponsor Name

Chart
Table

Sponsor Name for zanubrutinib
Sponsor	Trials
BeiGene	39
National Cancer Institute (NCI)	5
Ruijin Hospital	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for zanubrutinib
Sponsor	Trials
Other	78
Industry	52
NIH	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.